Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease

Eur J Med Chem. 2014 Jun 10:80:175-83. doi: 10.1016/j.ejmech.2014.04.050. Epub 2014 Apr 18.

Abstract

With the objective to formulate multifunctional nanosized liposomes to target amyloid deposits in Alzheimer Disease (AD) brains, a lipid-PEG-curcumin derivative was synthesized and characterized. Multifunctional liposomes incorporating the curcumin derivative and additionally decorated with a Blood Brain Barrier (BBB) transport mediator (anti-Transferin antibody) were prepared and characterized. The fluorescence intensity of curcumin derivative was found to increase notably when the curcumin moiety was in the form of a diisopropylethylamine (DIPEA) salt. Both curcumin-derivative liposomes and curcumin-derivative Anti-TrF liposomes showed a high affinity for the amyloid deposits, on post-mortem brains samples of AD patients. The ability of both liposomes to delay Aβ1-42 peptide aggregation was confirmed by Thioflavin assay. However, the decoration of the curcumin-derivative liposomes with the Anti-TrF improved significantly the intake by the BBB cellular model. Results verify that the attachment of an antibody on the curcumin-liposome surface does not block deposit staining or prevention of Aβ aggregation, while the presence of the curcumin-PEG-lipid conjugate does not reduce their brain-targeting capability substantially, proving the potential of such multifunctional NLs for application in Alzheimer disease treatment and diagnosis.

Keywords: Amyloid; Curcumin; Liposome; Multifunctional; Nanoparticle; Targeting.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Amyloid beta-Peptides / chemistry*
  • Biological Transport
  • Blood-Brain Barrier / drug effects
  • Blood-Brain Barrier / metabolism
  • Brain / drug effects*
  • Brain / metabolism
  • Curcumin / administration & dosage*
  • Curcumin / metabolism
  • Curcumin / pharmacology*
  • Curcumin / therapeutic use
  • Humans
  • Liposomes / chemistry*
  • Molecular Targeted Therapy*
  • Nanoparticles / chemistry
  • Peptide Fragments / chemistry*
  • Polyethylene Glycols / chemistry
  • Protein Multimerization / drug effects
  • Protein Structure, Secondary

Substances

  • Amyloid beta-Peptides
  • Liposomes
  • Peptide Fragments
  • amyloid beta-protein (1-42)
  • Polyethylene Glycols
  • Curcumin